MOLECULAR CHARACTERIZATION OF THE MIS TYPE II RECEPTOR
MIS II 型受体的分子表征
基本信息
- 批准号:2196367
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-08-22 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Mullerian inhibiting substance (MIS) is responsible for regression of
Mullerian ducts during the course of male reproductive tract development
and curiously, MIS is also expressed in both adult male testes and female
ovaries, albeit at much lower levels. It is a TGF-beta family protein
expressed in fetal Sertoli cells of the testis which transduces its
signal into the cell via a heteromeric complex of type I and II
receptors. The molecular mechanisms governing these processes are
largely unknown as is the role played by MIS in the adult. Our primary
goal is to identify and characterized the MIS receptor components in
order to delineate the molecular details of MIS-mediated regression of
Mullerian ducts and to determine the roles played by MIS in the adult.
We have cloned putative MIS type I and type II receptors in the
laboratory, R1 and pBS7, respectively, which are expressed in the
appropriate tissues in a temporal manner. The type I receptor is being
studied by others in the laboratory, whereas the molecular
characterization of the MIS type II receptor (pBS7), is the focus of this
proposal. We will confirm by qualitative and quantitative techniques
that pBS7 is the MIS type II receptor. We will perform gene disruption
in mice to determine the phenotype of type II receptor knockout.
Finally, we will study the 5' flanking region of the type II receptor in
order to better understand the molecular mechanism underlying its
transcriptional regulation. The results of these efforts will allow us
to understand the roles played by MIS in fetal development and in the
adult.
苗勒管抑制物质(MIS)是负责退化的,
男性生殖道发育过程中的苗勒管
而且奇怪的是,MIS也在成年男性睾丸和女性睾丸中表达,
卵巢,尽管水平要低得多。 它是一种TGF-β家族蛋白
在睾丸的胎儿支持细胞中表达,
通过I型和II型的异聚体复合物向细胞中传递信号
受体。 控制这些过程的分子机制是
很大程度上未知的是MIS在成人中所起的作用。 我们的首要
目的是识别和表征MIS受体成分,
为了描述MIS介导的退行性变的分子细节,
苗勒管,并确定MIS在成人中发挥的作用。
我们已经克隆了假定的MIS I型和II型受体,
实验室,R1和pBS 7,分别表达在
适当的组织在时间的方式。 I型受体被
其他人在实验室里研究,而分子
MIS II型受体(pBS 7)的表征是本发明的焦点。
提议 我们将通过定性和定量技术确认
pBS 7是MIS II型受体。 我们将进行基因破坏
以确定II型受体敲除的表型。
最后,我们将研究II型受体的5'侧翼区,
为了更好地了解其分子机制,
转录调控 这些努力的结果将使我们
了解MIS在胎儿发育中的作用,
成年人了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSE M. TEIXEIRA其他文献
JOSE M. TEIXEIRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSE M. TEIXEIRA', 18)}}的其他基金
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
- 批准号:
10004135 - 财政年份:2019
- 资助金额:
$ 2.37万 - 项目类别:
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
- 批准号:
10401333 - 财政年份:2019
- 资助金额:
$ 2.37万 - 项目类别:
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
- 批准号:
10621179 - 财政年份:2019
- 资助金额:
$ 2.37万 - 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
- 批准号:
8896094 - 财政年份:2013
- 资助金额:
$ 2.37万 - 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
- 批准号:
8679137 - 财政年份:2013
- 资助金额:
$ 2.37万 - 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
- 批准号:
8711586 - 财政年份:2013
- 资助金额:
$ 2.37万 - 项目类别:
相似海外基金
ERI: Non-Contact Ultrasound Generation and Detection for Tissue Functional Imaging and Biomechanical Characterization
ERI:用于组织功能成像和生物力学表征的非接触式超声波生成和检测
- 批准号:
2347575 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant
RUI: Spectroscopic Characterization and Low Temperature Kinetic Study of Hydrogenated Aromatic Radicals
RUI:氢化芳香族自由基的光谱表征和低温动力学研究
- 批准号:
2348916 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant
CAREER: atomistic characterization of protein-polymer conjugates
职业:蛋白质-聚合物缀合物的原子表征
- 批准号:
2339330 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Continuing Grant
A novel damage characterization technique based on adaptive deconvolution extraction algorithm of multivariate AE signals for accurate diagnosis of osteoarthritic knees
基于多变量 AE 信号自适应反卷积提取算法的新型损伤表征技术,用于准确诊断膝关节骨关节炎
- 批准号:
24K07389 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of dominant negative ACTA2 variants : a zebrafish model for non-syndromic aortic aneurysms
显性失活 ACTA2 变异的表征:非综合征性主动脉瘤的斑马鱼模型
- 批准号:
24K18891 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Characterization of the distribution and properties of inert copper in seawater
海水中惰性铜的分布和性质表征
- 批准号:
2343416 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant
Collaborative Research: TRTech-PGR TRACK: Discovery and characterization of small CRISPR systems for virus-based delivery of heritable editing in plants.
合作研究:TRTech-PGR TRACK:小型 CRISPR 系统的发现和表征,用于基于病毒的植物遗传编辑传递。
- 批准号:
2334028 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant
CAREER: Informed Testing — From Full-Field Characterization of Mechanically Graded Soft Materials to Student Equity in the Classroom
职业:知情测试 – 从机械分级软材料的全场表征到课堂上的学生公平
- 批准号:
2338371 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant
CAREER: Advancing ceramic processing science through acoustic characterization
职业:通过声学表征推进陶瓷加工科学
- 批准号:
2338898 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Continuing Grant
Thermospheric Estimation and CHaracterization with Nitric Oxide (TECHNO)
使用一氧化氮进行热层估计和表征 (TECHNO)
- 批准号:
2343844 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Standard Grant














{{item.name}}会员




